Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H5NO2 |
Molecular Weight | 123.1094 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC=NC=C1
InChI
InChIKey=TWBYWOBDOCUKOW-UHFFFAOYSA-N
InChI=1S/C6H5NO2/c8-6(9)5-1-3-7-4-2-5/h1-4H,(H,8,9)
Molecular Formula | C6H5NO2 |
Molecular Weight | 123.1094 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Isonicotinic acid considered to be inactive isomer of nicotinic acid. Isonicotinic acid is a metabolite of pyridine-4-carboxy hydrazide (isonicotinyl hydrazide; isoniazid) a front-line weapon in the battle against tuberculosis. Isonicotinic acid and its derivatives are used in manufacturing pharmaceuticals and agrochemicals.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEBI:16908 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12596216 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Antioxidant activity of new ruthenium compounds. | 2005 |
|
Synthesis and characterization of hydrogen-bonded assemblies of W6S8L6 clusters. | 2005 Apr 4 |
|
An investigation of the surface-enhanced Raman scattering (SERS) effect from a new substrate of silver-modified silver electrode. | 2005 Dec 15 |
|
A new layered zinc phosphate templated by protonated isonicotinate, [Zn2(C6H5NO2)2(HPO4)2]. | 2005 Feb |
|
A 3D coordination framework based on linkages of nanosized hydroxo lanthanide clusters and copper centers by isonicotinate ligands. | 2005 Feb 18 |
|
Ditopic redox-active polyferrocenyl zinc(II) dithiocarbamate macrocyclic receptors: synthesis, coordination and electrochemical recognition properties. | 2005 Feb 21 |
|
Dinuclear zinc(II) dithiocarbamate macrocycles: ditopic receptors for a variety of guest molecules. | 2005 Jan 21 |
|
Siloxane-supported organometallic compounds and their catalytic activities for the hydrosilylation of vinylsilanes and dienes. | 2005 Jan 7 |
|
Surface-enhanced Raman spectroscopy using silver-coated porous glass-ceramic substrates. | 2005 Jun |
|
A solvothermally in situ generated mixed-ligand approach for NLO-active metal-organic framework materials. | 2005 Jun 13 |
|
Clinical presentation of abdominal tuberculosis in HIV seronegative adults. | 2005 Jun 21 |
|
[Effects of a single dose of dexamethasone-21-isonicotinate on the phagocytosis performance of neutrophilic granulocytes and monocytes in periparturient dairy cows]. | 2005 Mar-Apr |
|
Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family. | 2005 May 15 |
|
Determination of ethylene thiourea in urine by HPLC-DAD. | 2005 May-Jun |
|
Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci. | 2005 Oct 6 |
|
Open metal-organic framework containing cuprate chains. | 2005 Sep 5 |
|
Synthesis, Biological, Spectral, and Thermal Investigations of Cobalt(II) and Nickel(II) Complexes of N-Isonicotinamido -2',4'-Dichlorobenzalaldimine. | 2006 |
|
The role of serendipity in drug discovery. | 2006 |
|
Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review. | 2006 |
|
First metal azide complex with isonicotinate as a bridging ligand showing new net topology: hydrothermal synthesis, structure, and magnetic properties. | 2006 Apr 3 |
|
Langerhans cells release prostaglandin D2 in response to nicotinic acid. | 2006 Dec |
|
Photosensitizers containing the 1,8-naphthyridyl moiety and their use in dye-sensitized solar cells. | 2006 Dec 11 |
|
A rash imposition from a lifestyle omission: a case report of pellagra. | 2006 Jan |
|
Aerobic biodegradation of 4-methylpyridine and 4-ethylpyridine by newly isolated Pseudonocardia sp. strain M43. | 2006 Jan |
|
Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods. | 2006 Jan 13 |
|
Acetylation genotype and phenotype in patients with systemic lupus erythematosus. | 2006 Jan-Feb |
|
Accurate length control of supramolecular oligomerization: Vernier assemblies. | 2006 Jul 12 |
|
Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction. | 2006 Mar-Apr |
|
Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid: differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis. | 2006 May |
|
Spontaneously resolved homochiral 3D lanthanide-silver heterometallic coordination framework with extended helical Ln-O-Ag subunits. | 2006 Nov 13 |
|
Coordination framework hosts consisting of 4-pyridyl-substituted carboxylic acid (PCA) dimers and 1D chains of Ni2+ and SCN-: a rational structural extension toward coordination framework hosts with large rectangular cavities. | 2006 Nov 13 |
|
A robust microporous 3D cobalt(II) coordination polymer with new magnetically frustrated 2D lattices: single-crystal transformation and guest modulation of cooperative magnetic properties. | 2006 Nov 28 |
|
Comparison of the anti-neoplastic effects of dirhodium(II) tetrapropionate and its adducts with nicotinate and isonicotinate anions in mice bearing Ehrlich tumors. | 2006 Oct |
|
Identification of a cytochrome P450 cDNA (CYP98A5) from Phaseolus vulgaris, inducible by 3,5-dichlorosalicylic acid and 2,6-dichloro isonicotinic acid. | 2007 Apr |
|
Surface modification of high-nuclearity lanthanide clusters: two tetramers constructed by cage-shaped [Dy26] clusters and isonicotinate linkers. | 2007 Apr 16 |
|
On the relevance of an antiferromagnetic dimer model for the spin-gapped magnetic solids Cu(terpy)Mo2O7 and Cu(OH)(p-pyc)H2O. | 2007 Apr 2 |
|
First direct-formation and properties of microspherical superstructure. Morphology of diamineplatinum(II) complexes with isonicotinate. | 2007 Feb 7 |
|
A deliberate approach for the syntheses of heterometallic supramolecules containing dimolybdenum Mo(2)4+ species coordinated to other metal units. | 2007 Jun 14 |
|
3D coordination framework [Ln(4)(mu(3)-OH)(2)Cu(6)I(5)(IN)(8)(OAc)(3)] (IN = isonicotinate): employing 2D layers of lanthanide wheel clusters and 1D chains of copper halide clusters. | 2007 Jun 25 |
|
Metallacrown-based compartments: selective encapsulation of three isonicotinate anions in non-centrosymmetric solids. | 2007 Mar 12 |
|
LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method. | 2007 Mar 12 |
|
A regenerable ruthenium tetraammine nitrosyl complex immobilized on a modified silica gel surface: preparation and studies of nitric oxide release and nitrite-to-NO conversion. | 2007 Mar 15 |
|
A series of lanthanide-transition metal frameworks based on 1-, 2-, and 3D metal-organic motifs linked by different 1D copper(I) halide motifs. | 2007 Nov 26 |
|
Study on complex formation of biologically active pyridine derivatives with cyclodextrins by capillary electrophoresis. | 2007 Nov 30 |
|
Amine modification of digested peptide at C-terminal end during protein digestion by protease. | 2007 Oct |
|
Antimalarial cation-dimers synthesized in two steps from an inexpensive starting material, isonicotinic acid. | 2007 Oct |
|
Diversity of crystal structure with different lanthanide ions involving in situ oxidation-hydrolysis reaction. | 2007 Sep 28 |
|
3D homometallic carboxylate ferrimagnet constructed from a manganese(II) succinate carboxylate layer motif pillared by isonicotinate spacers. | 2007 Sep 3 |
|
Linking two distinct layered networks of nanosized {Ln18} and {Cu24} wheels through isonicotinate ligands. | 2008 |
|
Epimers of bicyclo[2.2.2]octan-2-ol derivatives with antiprotozoal activity. | 2008 Apr |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5415834
Unknown
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26621144
Isonicotinic acid (1 mM), had no effect on Ca2+, glutamate, NO, or ROS levels in PC12 cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Jul 05 23:35:18 UTC 2023
by
admin
on
Wed Jul 05 23:35:18 UTC 2023
|
Record UNII |
Y8SYN761TQ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5922
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
55-22-1
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
M6503
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
6032
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
DTXSID8020757
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
100000126230
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
Y8SYN761TQ
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
SUB32870
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
200-228-2
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
1483
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY | |||
|
ISONICOTINIC ACID
Created by
admin on Wed Jul 05 23:35:18 UTC 2023 , Edited by admin on Wed Jul 05 23:35:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |